Key result
Mediterranean diet with olive oil cuts vitamin K antagonist initiation ~32% vs. low-fat diet.
Why the study?
It was unknown whether following a Mediterranean Diet decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with their use in older individuals at high cardiovascular risk.
Does following a Mediterranean diet enriched with extra-virgin olive oil or nuts reduce the initiation of antithrombotic therapies and attenuate the cardiovascular risk associated with their use in older adults at high cardiovascular risk?
RCT (n=6,772)
1:1:1
Yes
Does following a Mediterranean diet enriched with extra-virgin olive oil or nuts reduce the initiation of antithrombotic therapies and attenuate the cardiovascular risk associated with their use in older adults at high cardiovascular risk?
Adherence to a Mediterranean diet enriched with extra-virgin olive oil reduces the need to initiate vitamin K antagonist therapy by 32% and blunts the heightened cardiovascular event risk observed in patients taking these anticoagulants.
Answers are grounded in this paper and cite their sources.
Mediterranean diet with extra-virgin olive oil may delay vitamin K antagonist initiation in high-risk older adults; extends RCT evidence for its role in cardiovascular prevention.
Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvención con DIeta MEDiterránea (PREDIMED) study allocated to a MedDiet enriched in extra-virgin olive oil or nuts (versus a low-fat control intervention) disclose differences in the risk of initiation of: (1) vitamin K epoxide reductase inhibitors (acenocumarol/warfarin; n = 6772); (2) acetylsalicylic acid as antiplatelet agent (n = 5662); and (3) other antiplatelet drugs (cilostazol/clopidogrel/dipyridamole/ditazol/ticlopidine/triflusal; n = 6768). We also assess whether MedDiet modifies the association between the antithrombotic drug baseline use and incident cardiovascular events. The MedDiet intervention enriched with extra-virgin olive oil decreased the risk of initiating the use of vitamin K epoxide reductase inhibitors relative to control diet (HR: 0.68 [0.46–0.998]). Their use was also more strongly associated with an increased risk of cardiovascular disease in participants not allocated to MedDiet interventions (HRcontrol diet: 4.22 [1.92–9.30], HRMedDiets: 1.71 [0.83–3.52], p-interaction = 0.052). In conclusion, in an older population at high cardiovascular risk, following a MedDiet decreases the initiation of antithrombotic therapies and the risk of suffering major cardiovascular events among users of vitamin K epoxide reductase inhibitors.
No takes yet. Share an insight, caveat, or question.
Castro‐Barquero et al. (2020) conducted an RCT in High cardiovascular risk without baseline cardiovascular disease (n=6,772). Mediterranean diet enriched with extra-virgin olive oil or nuts vs. Low-fat control diet was evaluated on Initiation of vitamin K epoxide reductase inhibitors (acenocoumarol/warfarin) (HR 0.68, 95% CI 0.46-0.998, p=0.049). Mediterranean diet enriched with extra-virgin olive oil reduced the risk of initiating vitamin K epoxide reductase inhibitors by 32% compared to a low-fat diet.
Synapse has enriched 10 related papers. Consider them for comparative context: